🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Domenico Bellomo

ORCID: 0000-0003-2289-5944

MedicineBiochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Identification of stage IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.”.

Identification of stage IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22088

N/A

0DataRank · unranked

3 citations

Félicia Tjien-Fooh, Domenico Bellomo, Enrica Quattrocchi, Sindhuja Sominidi Damodaran, M. van Vliet +4 more

Using a clinicopathologic and gene expression model to identify melanoma patients at high risk for disease relapse.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10068

N/A

0DataRank · unranked

0 citations

Domenico Bellomo, Félicia Tjien-Fooh, Renske Wever, Enrica Quattrocchi, Sindhuja Sominidi Damodaran +4 more

The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

European Journal of Cancer(2021)10.1016/j.ejca.2021.08.042

N/A

0DataRank · unranked

1 citations

Domenico Bellomo, Jvalini Dwarkasing, Lisette Meerstein‐Kessel, Alexander Meves, Alexander M.M. Eggermont